Screening of ROS1 Rearrangements in Lung Adenocarcinoma by Immunohistochemistry and Comparison with ALK Rearrangements

ROS1 rearrangement is a predictive biomarker for response to the tyrosine kinase inhibitor, crizotinib. We investigated the usefulness of ROS1 immunohistochemistry (IHC) for the detection of patients who harbor ROS1 rearrangements in two separate cohorts. We also compared ROS1 IHC with ALK IHC in te...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Cha, Yoon Jin, Lee, Jae Seok, Kim, Hye Ryun, Lim, Sun Min, Cho, Byoung Chul, Lee, Chang Young, Shim, Hyo Sup
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Public Library of Science 2014
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4109990/
https://ncbi.nlm.nih.gov/pubmed/25058391
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0103333
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia